These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8328104)

  • 41. Evaluation of alginate based mesalazine tablets for intestinal drug delivery.
    Tuğcu-Demiröz F; Acartürk F; Takka S; Konuş-Boyunağa O
    Eur J Pharm Biopharm; 2007 Sep; 67(2):491-7. PubMed ID: 17451926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties.
    Tromm A; Griga T; May B
    Hepatogastroenterology; 1999; 46(30):3124-35. PubMed ID: 10626173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myocarditis by mesalazine with cardiac magnetic resonance imaging.
    García-Ferrer L; Estornell J; Palanca V
    Eur Heart J; 2009 Apr; 30(8):1015. PubMed ID: 19168869
    [No Abstract]   [Full Text] [Related]  

  • 44. Pancreatitis induced by 5-aminosalicylic acid.
    Deprez P; Descamps C; Fiasse R
    Lancet; 1989 Aug; 2(8660):445-6. PubMed ID: 2569623
    [No Abstract]   [Full Text] [Related]  

  • 45. Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease.
    Mulder CJ; van den Hazel SJ
    Mediators Inflamm; 1998; 7(3):135-6. PubMed ID: 9705596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current medical treatment of inflammatory bowel disease].
    Bosques-Padilla F
    Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():92-101. PubMed ID: 18277494
    [No Abstract]   [Full Text] [Related]  

  • 47. Oral mesalamine formulation to be marketed.
    Clin Pharm; 1993 Aug; 12(8):555. PubMed ID: 8222518
    [No Abstract]   [Full Text] [Related]  

  • 48. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.
    Hanauer S; Schwartz J; Robinson M; Roufail W; Arora S; Cello J; Safdi M
    Am J Gastroenterol; 1993 Aug; 88(8):1188-97. PubMed ID: 8338086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The suspension of an announced trial on relapse prevention in Crohn's ileitis with a 5-ASA formulation in microgranular form.
    Prantera C; Bellinvia S
    Dig Liver Dis; 2005 Feb; 37(2):135-6. PubMed ID: 15733528
    [No Abstract]   [Full Text] [Related]  

  • 50. Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life.
    Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E;
    Am J Gastroenterol; 2002 Mar; 97(3):649-53. PubMed ID: 11922560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [5-Aminosalicylic acid enema preparation].
    René E; Farinotti R; Mignon M; Cerf M; Dauphin A; Bonfils S
    Gastroenterol Clin Biol; 1983 Nov; 7(11):935. PubMed ID: 6653982
    [No Abstract]   [Full Text] [Related]  

  • 52. Correction of mesalazine-induced neutropenia with high-dose G-CSF.
    Bhidayasiri R; Katz JA; Sokos DR
    Am J Gastroenterol; 2000 Nov; 95(11):3321-2. PubMed ID: 11095375
    [No Abstract]   [Full Text] [Related]  

  • 53. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.
    Tursi A; Brandimarte G; Giorgetti GM; Forti G; Modeo ME; Gigliobianco A
    Med Sci Monit; 2004 Nov; 10(11):PI126-31. PubMed ID: 15507864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crohn's disease and acute leukocytoclastic vasculitis of skin.
    Zlatanic J; Fleisher M; Sasson M; Kim P; Korelitz BI
    Am J Gastroenterol; 1996 Nov; 91(11):2410-3. PubMed ID: 8931427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delivery of 5-aminosalicylate to the guinea pig cecum.
    Salata K; Dull BJ; Goldman P
    Biochem Pharmacol; 1987 Jan; 36(2):295-7. PubMed ID: 3814172
    [No Abstract]   [Full Text] [Related]  

  • 56. [Experimental study on dichlortetracycline with pasomycin complex].
    Shevniuk LA; Ved'mina EA; Urianskaia VN; Braude AI
    Antibiotiki; 1968 Jun; 13(6):483-9. PubMed ID: 4175869
    [No Abstract]   [Full Text] [Related]  

  • 57. [A case of nonspecific inflammation of the large and small intestine treated with the preparation TFX].
    Kiczka W; Hasik J; Kulesza-Kiczka M; Adamek J; Czarnecki J; Jaskólski B; Stachowiak C; Lawniczak C
    Pol Tyg Lek; 1986 Feb; 41(6):187-9. PubMed ID: 3714558
    [No Abstract]   [Full Text] [Related]  

  • 58. [Drug induced steatorrhea].
    Wagner A
    Hippokrates; 1971 Jun; 42(2):226-8. PubMed ID: 5566030
    [No Abstract]   [Full Text] [Related]  

  • 59. [On the pharmacokinetics of rapid PAS infusions].
    Bercea O; Marcian S
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):256-7. PubMed ID: 5755194
    [No Abstract]   [Full Text] [Related]  

  • 60. Response to Dhoble et al.
    Fumery M; Allez M
    Am J Gastroenterol; 2017 Sep; 112(9):1479-1480. PubMed ID: 28874871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.